PT - JOURNAL ARTICLE AU - John A. Lednicky AU - Massimiliano S. Tagliamonte AU - Sarah K. White AU - Maha A. Elbadry AU - Md. Mahbubul Alam AU - Caroline J. Stephenson AU - Tania S. Bonny AU - Julia C. Loeb AU - Taina Telisma AU - Sonese Chavannes AU - David A. Ostrov AU - Carla Mavian AU - Valerie Madsen Beau De Rochars AU - Marco Salemi AU - J. Glenn Morris, Jr. TI - Emergence of porcine delta-coronavirus pathogenic infections among children in Haiti through independent zoonoses and convergent evolution AID - 10.1101/2021.03.19.21253391 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.19.21253391 4099 - http://medrxiv.org/content/early/2021/03/25/2021.03.19.21253391.short 4100 - http://medrxiv.org/content/early/2021/03/25/2021.03.19.21253391.full AB - Coronaviruses have caused three major epidemics since 2003, including the ongoing SARS-CoV-2 pandemic. In each case, coronavirus emergence in our species has been associated with zoonotic transmissions from animal reservoirs1,2, underscoring how prone such pathogens are to spill over and adapt to new species. Among the four recognized genera of the family Coronaviridae – Alphacoronavirus, Betacoronavirus, Deltacoronavirus, Gammacoronavirus, – human infections reported to date have been limited to alpha- and betacoronaviruses3. We identify, for the first time, porcine deltacoronavirus (PDCoV) strains in plasma samples of three Haitian children with acute undifferentiated febrile illness. Genomic and evolutionary analyses reveal that human infections were the result of at least two independent zoonoses of distinct viral lineages that acquired the same mutational signature in the nsp15 and the spike glycoprotein genes by convergent evolution. In particular, structural analysis predicts that one of the changes in the Spike S1 subunit, which contains the receptor-binding domain, may affect protein’s flexibility and binding to the host cell receptor. Our findings not only underscore the ability of deltacoronaviruses to adapt and potentially lead to human-to-human transmission, but also raise questions about the role of such transmissions in development of pre-existing immunity to other coronaviruses, such as SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWork was supported in part by a grant (R01-AI123657S1) from NIAID to JGM.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study has been reviewed and approved by the University of Florida IRB and the Haitian National IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPDCoV sequences are available through GenBank, with GenBank accession numbers provided in Table 1. Data on strains used in the phylogenetic analysis are included in Supplemental Table S1.